SCHEMBL7120415

SCHEMBL7120415

CC(C)c1c(O[Si](C)(C)C(C)(C)C)nc2ccc(F)cc2c1OC#CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7549488 0.91 TNKS (0.32)
SCHEMBL7123408 0.77 AAK1 (0.33)
SCHEMBL7113376 0.66 RORC (0.38)
SCHEMBL7119299 0.63 DHODH (0.34)
SCHEMBL30080029 0.58 ALOX5AP (0.36)
SCHEMBL22275198 0.56 CA12 (0.34)
SCHEMBL6811874 0.55 CA12 (0.56)
SCHEMBL30079900 0.55 ESR1 (0.39)
SCHEMBL1056366 0.54 ALOX5AP (0.36)
SCHEMBL30080022 0.54 HSD11B1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069271-A1 Quinolone compounds for use in treating viral infections SMITHKLINE BEECHAM CORPORATION 2003-04-10 US disclosed
EP-1244629-A2 QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS GLAXO GROUP LIMITED (GB) 2002-10-02 EP disclosed
WO-2001046150-A2 QUINOLONE COMPOUNDS FOR USE IN TREATING VIRAL INFECTIONS GLAXO GROUP LIMITED (GB) 2001-06-28 WO disclosed